Examiner Richard L. Manteuffel

Appears inactive Last observed office action: January 2015 (134 months ago).

Examiner Richard L. Manteuffel appears to be very easy relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 45.7%, they average 1.81 office actions per granted patent, and their rejection profile is dominated by §103.

Difficulty vs AU Very Easy

Difficulty vs Group Very Easy

Difficulty vs TC Very Easy

Difficulty vs USPTO About Average

Average OA / Grant 1.81

Export

Word PDF

Create account to export.

Examiner Details

Observed Examiner Years: 4 years (2012-2015)
Tech Center: 1600 - Biotechnology and Organic
Group: 1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated: 35
Granted Applications: 16
Non-Granted Applications: 19
Avg OA / Grant: 1.81
Last OA Observed: January 2015 (134 months ago)
Art Units Seen: 1639
Work Groups Seen: 1630 - Stem Cells and Nucleic Acid Related Therapy

Context Comparison

Scope	Examiners	Lifetime Grant Ratio	Avg OA / Grant
This Examiner	1	45.7%	1.81
Art Unit	18	45.5%	2.16
Group	243	38.4%	2.18
Tech Center	1,349	39.5%	2.02
USPTO	16,116	54.8%	1.98

Grant Timeline

Shaded region marks the last two observed years, where grant outcomes may lag due to recency.

Year	Applications	Granted	Grant Rate
No observed data before 2012; examiner may not yet have been active in the available dataset.
2012	3	2	66.7%
2013	13	7	53.8%
2014	17	7	41.2%
2015	2	0	0.0%
No observed data after 2015; examiner may have gone inactive or moved out of examining work.

16 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA #	Office Actions	§ 101 Percentage	§ 102 Percentage	§ 103 Percentage	§ 112 Percentage
1	35	0.0%	20.0%	65.7%	2.9%
2	22	0.0%	18.2%	72.7%	9.1%
3	7	0.0%	0.0%	57.1%	14.3%
4	4	0.0%	0.0%	75.0%	0.0%
5	2	0.0%	0.0%	100.0%	0.0%
6	1	0.0%	0.0%	100.0%	0.0%